Drugmakers Pause Trials in Russia While Still Sending Medicine
- Several companies have halted study recruitment in Russia
- Drugmakers, medical-device makers remain exempt from sanctions
Pfizer headquarters in New York.
Photographer: Stephanie Keith/Bloomberg
This article is for subscribers only.
Top pharmaceutical companies in the U.S. and Europe said they’re halting recruitment for clinical trials in Russia, while continuing to send medicine and other health supplies to help those in need.
Drugmakers including Pfizer Inc., Johnson & Johnson, Merck & Co., Roche Holding Ag and Bristol Myers Squib Co. are seeking to strike a balance between international opprobrium over Russia’s invasion of Ukraine and the needs of sick patients.